Don Lehr
General Counsel bei PRECIGEN, INC.
Vermögen: 753 376 $ am 30.04.2024
Aktive Positionen von Don Lehr
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PRECIGEN, INC. | General Counsel | 01.01.2009 | - |
| Unternehmenssekretär | - | - | |
Genten Therapeutics, Inc.
 Genten Therapeutics, Inc. BiotechnologyHealth Technology Genten Therapeutics, Inc. operates as a biotechnology firm. It delivers a monotherapy through an antigen-specific induction of immune tolerance for gluten to address unmet medical need. The company is headquartered in San Francisco, CA. | Vorstandsvorsitzender | - | - |
| Unternehmenssekretär | - | - |
Karriereverlauf von Don Lehr
Ehemalige bekannte Positionen von Don Lehr
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENVEC INC | Direktor/Vorstandsmitglied | 16.06.2017 | - |
| Präsident | 16.06.2017 | - | |
| Treasurer | 16.06.2017 | - |
Ausbildung von Don Lehr
| Swarthmore College | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| The University of Maryland Francis King Carey School of Law | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Secretary | 2 |
| Graduate Degree | 2 |
| General Counsel | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Genten Therapeutics, Inc.
Genten Therapeutics, Inc. BiotechnologyHealth Technology Genten Therapeutics, Inc. operates as a biotechnology firm. It delivers a monotherapy through an antigen-specific induction of immune tolerance for gluten to address unmet medical need. The company is headquartered in San Francisco, CA. | Health Technology |
